[144] RINGCENTRAL, INC. SEC Filing
Rhea-AI Filing Summary
Form 144 notice for RingCentral, Inc. (RNG) discloses a proposed sale of 2,443 shares of common stock through Morgan Stanley Smith Barney with an aggregate market value of $75,000.10, to be sold approximately on 08/18/2025 on the NYSE. The filing reports the shares were acquired as restricted stock on 08/15/2025 and that payment was made on that date.
The filing also lists a prior sale by the same person on 05/21/2025 of 10,076 shares for gross proceeds of $270,854.97. The issuer’s reported outstanding shares are 90,542,720. The filer certifies they are not aware of undisclosed material adverse information.
Positive
- Transaction disclosed under Rule 144, showing regulatory compliance with required broker, amounts, and acquisition details
- Prior sale disclosed (05/21/2025: 10,076 shares, $270,854.97), providing transparency about recent insider transactions
- Relatively small size of the proposed sale ($75,000.10) versus the reported 90,542,720 shares outstanding
Negative
- Multiple insider sales within three months are reported (May and August), which may be material to some investors’ monitoring of insider activity
Insights
TL;DR: Routine insider sale notice; modest size versus total shares outstanding, previously executed sales also disclosed.
The Form 144 is procedural, documenting a proposed sale of 2,443 restricted shares acquired on 08/15/2025 and planned for sale on 08/18/2025 through Morgan Stanley Smith Barney. The aggregate market value is stated as $75,000.10 against 90,542,720 shares outstanding, indicating the transaction is small in absolute and relative terms. The filing also records a prior sale on 05/21/2025 of 10,076 shares for $270,854.97. There are no disclosures here of material operational or financial developments for the issuer.
TL;DR: Compliance-focused filing; includes required representation about non-public material information and prior insider sale history.
The document meets Rule 144 disclosure requirements by identifying the broker, class, amounts, acquisition details, and recent sales. It includes the signer’s attestation regarding absence of undisclosed material adverse information and references Rule 10b5-1 when applicable. No governance issues, restrictions, or unusual conditions are stated in the filing text provided.